RenalSense

About:

RenalSense is building a Realtime Diagnostic Platform for Acute Kidney Injury (AKI) in Critical Care: Detection, Prevention, Management

Website: http://www.renalsense.com

Top Investors: Israel Innovation Authority, BlueRed Partners

Description:

While prevention of kidney injury is highly dependent on early detection of potential risk, the industry has no solutions to address this need. Conventional products and protocols can only report kidney damage after it exists - not prevent it. The growing unmet need for early detection and prevention of risk and for the tools to improve the management of AKI patients in critical care have established the necessity of realtime renal diagnostics solutions. RenalSense's unique products will set new clinical gold standards, improve outcomes and reduce the cost of care.